|
|
ED Treatment
Swine Flu Treatment
Recently Added
Recent News
03/10/10 Symmetry Medical reports gross profit of .0M for fourth-quarter 2009
03/10/10 Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM 03/10/10 Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures Top Category's Bestsellers
Psoriasis TreatmentPsoriasis is a wide-spread skin disease distinguished by swelling and redness of the knees, soles of the feet, palms, scalp, lower back, and other locations. Inflamed area of the skin is usually covered with silvery scales that are itchy and feel sore. Other symptoms of psoriasis may vary depending on specific psoriasis type a person experience. People who experience pustular psoriasis usually develop blisters on the skin that are often thick with noninfectious pus. While inverse psoriasis is characterized by developing smooth and red patches that occur under the breast, near the genitals or in the armpits. Guttae psoriasis results in small, drop-shaped lesions of the lower extremities, scalp and trunk. What actually causes psoriasis is still not known. It is considered that immune blood cells called T-cells, which normally protect human organism from foreign substances and infection, receive irregular signal and are put into action by mistake. This results in fast turnover and swelling of skin cells. In some cases hereditary factor, stress, infection and changes in weather may lead to any types of psoriasis. Before beginning psoriasis treatment your health care provider should precise what type of psoriasis you experience as well as the severity of the disease and size of the involved areas. Usually psoriasis treatment include "1-2-3" approach.
Category News
05/07/07 - RELIEVA Psoriasis Treatment Captures Attention Of The American Journal Of Therapeutics - Clinical Results Support Impressive Conclusions
Psoriasis is a common immune-meditated chronic skin disease often characterized as red, scaly plaques that itch, burn, sting, and bleed easily. Psoriasis afflicts approximately 125 million people worldwide; more than 90% of patients have the mild to mode
02/07/07 - People With Chronic Moderate To Severe Plaque Psoriasis May Be Undertreated
The National Psoriasis Foundation and Amgen (NASDAQ: AMGN), has announced survey findings which show that nearly 40 percent of 1,142 patients surveyed with chronic moderate or severe psoriasis are not currently receiving any treatment. These results were
02/06/07 - Psoriasis Patients Show Significant Improvement In Symptoms With Abbott's HUMIRA® In New Phase III Study
Psoriasis patients experienced a significant reduction in the signs of their disease when treated with Abbott's HUMIRA® (adalimumab), and they were significantly less likely to have their diseas...
02/05/07 - Psoriasis Patients Show Significant Improvement In Symptoms With Abbott's HUMIRA(R) In New Phase III Study
Psoriasis patients experienced a significant reduction in the signs of their disease when treated with Abbott's HUMIRA(R) (adalimumab), and they were significantly less likely to have their di... |